XYLASED 100 mg/ml injekčný roztok
XYLASED 100 mg/ml injekčný roztok
Authorised
- Xylazine hydrochloride
Product identification
Medicine name:
XYLASED 100 mg/ml injekčný roztok
Active substance:
- Xylazine hydrochloride
Target species:
-
Cattle
-
Horse
Route of administration:
-
Intramuscular use
-
Intravenous use
Product details
Active substance and strength:
-
Xylazine hydrochloride116.55milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Cattle
-
Meat and offal3day
-
Milk36hour
-
-
Intravenous use
- Cattle
-
Meat and offal3day
-
Milk36hour
-
- Horse
-
Meat and offalno withdrawal periodDo not use in animals, which are intended to produce meat for human consumption.
-
Milkno withdrawal periodDo not use in animals, which are intended to produce milk for human consumption.
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN05CM92
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Slovakia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
- 96/005/17-S
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Slovak (PDF)
Published on: 7/03/2023
How useful was this page?: